MedicineWatch US
Class II Recall

Teva Pharmaceuticals USA

Product
Idarubicin Hydrochloride Injection 20 mg/20 mL, 20 mL single-dose vial, Rx only, Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0703-4156-11
Reason
Lack of Assurance of Sterility
Classification
Class II
Status
Terminated
Lot
Lot #: 31328668B, exp. date 04/2023
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.